Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating activities:
Net income (loss)	$ 88	$ 58	$ (1,048)	$ (1,152)
Adjustments to reconcile net income (loss) to net cash provided by operations:
Depreciation and amortization	283	321	887	1,002
Impairment of goodwill, long-lived assets and assets held for sale	48	28	1,010	1,002
Net change in operating assets and liabilities	(238)	93	(398)	1,007
Deferred income taxes – net and uncertain tax positions	(199)	44	(349)	(1,214)
Stock-based compensation	31	26	93	88
Other items	(3)	(40)	20	(117)
Net loss (gain) from investments and from sale of long lived assets	(5)	13	(31)	1
Net cash provided by (used in) operating activities	5	543	184	617
Investing activities:
Beneficial interest collected in exchange for securitized trade receivables	362	262	1,056	854
Purchases of property, plant and equipment and intangible assets	(149)	(122)	(407)	(406)
Proceeds from sale of business and long lived assets	10	2	68	45
Acquisition of businesses, net of cash acquired	0	0	0	(7)
Purchases of investments and other assets .	(38)	2	(44)	(2)
Other investing activities	(1)	3	(6)	4
Net cash provided by (used in) investing activities	184	147	667	488
Financing activities:
Repayment of senior notes and loans and other long term liabilities	(1,000)	(365)	(4,152)	(661)
Proceeds from senior notes, net of issuance costs	0	0	2,451	0
Proceeds from short term debt	700	0	700	0
Repayment of short term debt	(200)	0	(200)	0
Other financing activities	(76)	(75)	(136)	(115)
Net cash provided by (used in) financing activities	(576)	(439)	(1,337)	(776)
Translation adjustment on cash and cash equivalents	(33)	(84)	(98)	(269)
Net change in cash, cash equivalents and restricted cash	(420)	167	(584)	60
Balance of cash, cash equivalents and restricted cash at beginning of period	2,670	2,091	2,834	2,198
Balance of cash, cash equivalents and restricted cash at end of period	2,250	2,258	2,250	2,258
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:
Cash and cash equivalents	2,249	2,225	2,249	2,225
Restricted cash included in other current assets . .	1	33	1	33
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	2,250	2,258	2,250	2,258
Non-cash financing and investing activities:
Beneficial interest obtained in exchange for securitized accounts receivables	376	293	1,090	883
Dividend declared to non-controlling interests	$ 67	$ 0	$ 67	$ 0